Another Piece in the Diabetes and Multivessel Coronary Disease Puzzle

Affiliations

¹ Academic Affairs, Cedars-Sinai Health System, Los Angeles, California, USA. Electronic address: michael.farkouh@cshs.org.
² Swedish Hospital NorthShore University Health System, Chicago, Illinois, USA.

Free article

Editorial

Michael E Farkouh et al. JACC Cardiovasc Interv. 2023.

Free article

. 2023 Oct 9;16(19):2423-2425.

doi: 10.1016/j.jcin.2023.08.035.

¹ Academic Affairs, Cedars-Sinai Health System, Los Angeles, California, USA. Electronic address: michael.farkouh@cshs.org.
² Swedish Hospital NorthShore University Health System, Chicago, Illinois, USA.

No abstract available

Keywords: diabetes; outcomes; revascularization.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.
Kim H, Kang DY, Ahn JM, Lee J, Choi Y, Hur SH, Park HJ, Tresukosol D, Kang WC, Kwon HM, Rha SW, Lim DS, Jeong MH, Lee BK, Huang H, Lim YH, Bae JH, Kim BO, Ong TK, Ahn SG, Chung CH, Park DW, Park SJ; BEST Extended Follow-Up Study Investigators. Kim H, et al. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2412-2422. doi: 10.1016/j.jcin.2023.07.028. JACC Cardiovasc Interv. 2023. PMID: 37821187 Clinical Trial.